Bio-Rad Labs (BIO) Misses Q4 EPS by 20c; offers outlook Feb 12, 2026 04:16PM
Bio-Rad Labs (BIO) Tops Q3 EPS by 31c, provides outlook Oct 29, 2025 04:17PM
Bio-Rad co-founder Alice Schwartz dies at 99 Sep 30, 2025 06:08AM
UBS highlights Bio-Rad Labs' (BIO) margin expansion opportunity, reiterates Buy rating Aug 27, 2025 08:50AM
RBC Capital: 'We Are Buyers of Bio-Rad Labs (BIO)'; PT Raised to $409 Aug 1, 2025 10:09AM


Jul 31, 2025 04:16PM Bio-Rad Labs (BIO) Tops Q2 EPS by 88c; updates outlook
Jul 28, 2025 04:15PM Bio-Rad names Rajat Mehta executive vice president of global operations
Jul 7, 2025 09:01AM Bio-Rad launches four new digital PCR platforms following acquisition
Jun 5, 2025 07:01AM Cantor Fitzgerald: BIO CEO says US Needs a Biomanufacturing Renaissance
May 1, 2025 04:23PM Bio-Rad Labs (BIO) Tops Q1 EPS by 74c; updates outlook
Apr 15, 2025 04:46PM Qiagen (QGEN) said targeted by activist Fivespan Partners
Mar 28, 2025 05:08AM Bio-Rad Labs (BIO) PT Lowered to $285 at Jefferies
Mar 24, 2025 04:06PM OncoCyte (OCX) Reports Successful 2024; Sets Stage for 2025 Catalysts
Feb 14, 2025 09:19AM Bio-Rad Labs (BIO) PT Lowered to $400 at Citi
Feb 13, 2025 04:25PM Bio-Rad Labs (BIO) Tops Q4 EPS by 4c; offers outlook
Feb 13, 2025 04:15PM Bio-Rad Labs (BIO) to Acquire Stilla Technologies
Feb 10, 2025 08:31AM OncoCyte (OCX) prices $29.1 million equity offering at $2.05 per share
Oct 30, 2024 04:20PM Bio-Rad Labs (BIO) Tops Q3 EPS by 85c, Beats on Revenue
Oct 1, 2024 05:34AM Citi Upgrades Bio-Rad Labs (BIO) to Buy
Sep 6, 2024 05:26PM Palantir, Dell to join S&P 500
Aug 20, 2024 08:32AM Bio-Rad Labs (BIO) Appoints Jon DiVincenzo as COO
Aug 1, 2024 04:27PM Bio-Rad Labs (BIO) Tops Q2 EPS by $1.10, Misses on Revenue; Offers Q3 Guidance
Jun 10, 2024 04:12AM Citi Reiterates Neutral Rating on Bio-Rad Labs (BIO)
May 8, 2024 04:30PM This stock offers one of the most favorable long-term risk/rewards in biotech: RBC